Skip to content
StockMarketAgent
Direct answer
XOM trades against a final fair-value range of $113.02-$174.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $113, high $175, with mid-point at $139.
Stock analysis

XOM Exxon Mobil Corporation fair value $139–$175

XOM
By StockMarketAgent.AI team· supervised by
Analyzed: 2026-05-08Next update: 2026-08-08Methodology v2.4Archetype: CyclicalNYSE · Energy
View archive
Last price
$144.64
▼ -5.19 (-3.59%)
Fair value
$139
$139–$175
Rating
Hold
confidence 81/100
Upside
-3.6%
upside to fair value
Margin of Safety
$118.53
buy below · 15%
Market Cap
$599.5B
P/E fwd 14.2

§1 Executive summary

  • Composite fair value $139 with high case $175.
  • Implied downside of 3.6% to fair value.
  • Moat 6.5/10 · confidence 81/100 · Cyclical.
  • Trades close to fair value, so the margin of safety is limited either way.
Fair value
$139
Margin of safety
-3.7%
Confidence
81/100
Moat
6.5/10

Educational analysis only — not financial advice. Always do your own due diligence.

$144.64Price
FV $139.45
High $174.69

XOM trades against a final fair-value range of $113.02-$174.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Scale and Cost Advantage
    Premier integrated upstream and downstream operations provide structural cost advantages and margin capture across the entire value chain.
  • Asset Quality
    Highly advantaged upstream positioning, particularly in the Permian Basin and Guyana, secures long-duration, low-breakeven production.
  • Bull thesis
    Hold rating driven by limited upside to our $139.45 fair value estimate and high cycle timing uncertainty.

§2 Bear case

A rapid acceleration of global energy transition policies combined with a synchronized global recession would severely compress both volumes and realized margins. In this scenario, Exxon's heavy upstream capital commitments become stranded or yield sub-cost-of-capital returns, forcing a structural downward re-rating of the terminal multipleTerminal multipleThe exit P/E or EV/EBITDA we apply to the final year of an explicit forecast. Anchored to the business's long-run quality and the prevailing risk-free rate. well below the 12x cyclical floor.

Ways this thesis can break

Commodity Price Collapse

· Low

A sustained structural decline in crude oil prices below $50/bbl due to chronic oversupply and weakening demand, rendering marginal upstream assets economically unviable.

FV impact
Downside to $81.71 (5.8% discount rate, 1.0% terminal growth)
Trigger
2-3 Years

Stranded Asset Realization

· Medium

Aggressive global environmental regulations and carbon pricing mechanisms force the premature write-down of significant long-duration upstream and downstream reserves.

FV impact
Downside below $113.02 floor
Trigger
5-7 Years

Capital Misallocation Deflation

· Medium

The current $25.9B peak capital expenditure cycle fails to generate requisite returns, structurally depressing ROIC and forcing a persistent discount to net asset value.

FV impact
Downside to $103.04
Trigger
3-5 Years
Early-warning signals to monitor
MetricCurrentTrigger threshold
Operating margins compress below the 11.57% historical mid-cycle median.MonitorDeterioration versus the report thesis
Capital expenditures systematically exceed targeted peak levels without revenue proportionality.MonitorDeterioration versus the report thesis
Operating cash flow to net income ratio falls below 1.2x, signaling earnings quality degradation.MonitorDeterioration versus the report thesis
Significant downward revisions in upstream reserve life or realization estimates.MonitorDeterioration versus the report thesis
Failure to maintain a 14x terminal multiple due to shifting institutional ESG mandates.MonitorDeterioration versus the report thesis

§3 Financial history

Income statement — last six periods
Line itemT−0T−1T−2T−3T−4CAGR
Period2021-12-312022-12-312023-12-312024-12-312025-12-31Trend
Revenue$398.68B$334.70B$339.25B$323.91B-5.1%
Gross profit$103.07B$84.14B$76.74B$71.24B-8.8%
Operating income$64.03B$44.46B$39.65B$33.94B-14.7%
Net income$55.74B$36.01B$33.68B$28.84B-15.2%
EPS (diluted)$5.39$13.26$8.89$7.84$6.70+5.6%
EBITDA$102.59B$74.27B$73.31B$67.86B-9.8%
R&D
SG&A$10.10B$9.92B$9.98B$11.13B+2.5%

Quality scores

Piotroski F-score
5 / 9
0–9 quality composite
Altman Z-score
4.54
Bankruptcy risk (>3 safe)
OCF / Net income
1.8×
>1 indicates high earnings quality
Accounting quality gate
Pass
Sector-adjusted gate
ROIC
10.9%
Return on invested capital
§3

Numbers analysis

Individual subscribers — §4 onwards11 more sections

Read the full analysis — 11 more sections.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Full report for every covered ticker
24 months of rating archive
Watchlist briefings + rating-change alerts
PDF + DOCX export in any language
Start free trial
Cancel anytime.
FAQ

XOM — frequently asked questions

  1. Based on our latest independent analysis, XOM trades close to fair value. The current price is $145 versus a composite fair-value midpoint of $139 (range $113–$175), which implies roughly 3.6% downside to the midpoint.
Related coverage

Names readers of XOM also follow

Same archetype: cyclical